Crotylbarbital
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
| |
CAS Number | 1952-67-6 Y |
PubChem (CID) | 5364821 |
ChemSpider | 4516954 Y |
ECHA InfoCard | 100.016.162 |
Chemical and physical data | |
Formula | C10H14N2O3 |
Molar mass | 210.23 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Crotylbarbital (Mepertan, Kalipnon, Barotal), also known as crotarbital, is a barbiturate derivative developed by Eli Lilly in the 1930s[1]m It has sedative and hypnotic effects,[2] and was used for the treatment of insomnia until it was replaced by newer alternative drugs with less side effects and lower risk of overdose.
See also
References
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids | |
Imidazoles | |
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
See also: GABAergics |
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.